To investigate blood pressure (BP) as well as other risk factors before the onset of myocardial infarction in hypertensive patients, we analysed the BP and metabolic variables in 94 hypertensive patients who had been followed up in our out-patient clinic before the first onset (M1 group; n ‫؍‬ 42, 69 ؎ 1 years, mean ± s.e.) or the recurrent onset (M2 group; n ‫؍‬ 52, 69 ؎ 1 years) of myocardial infarction. Ninety-four hypertensive outpatients who had no history of serious cardiovascular diseases (C group) were also recruited for an age-and sex-matched case-control study. The majority of the patients were taking anti-hypertensive drugs (M1: 90%; M2: 98%; C: 90%). The average BP values for 1 year before the onset of myocardial infarction were used for the analysis. The BPs before the onset of myocardial infarction were 147 ؎ 2 mm Hg systole and 81 ؎ 2
Introduction
Both epidemiological data 1, 2 and clinical trials 3, 4 have shown that anti-hypertensive treatment leads to the prevention of stroke in hypertensive patients. Conversely, a number of studies have suggested that it may be harmful to lower blood pressure (BP), especially diastolic BP, too far, because the relationship between treated BP and the risk of myocardial infarction appears to be a J-or U-curve.
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Cruickshank et al 10 showed that a U-curve relation existed for diastolic BP and coronary heart disease deaths in patients with myocardial infarction but not for low-risk subjects without myocardial infarction. Other investigators have found that the existence of low diastolic BP was associated with increases in both cardiovascular and non-cardiovascular mortality in elderly hypertensive patients. 11, 12 However, these findings were obtained mainly by using the BP values at the initial screening visits alone; to the best of our knowledge, few mm Hg diastole in the M1 group, and 141 ؎ 2 mm Hg systole and 78 ± 1 mm Hg diastole in the M2 group, while those of the C group were 146 ؎ 1 mm Hg systole and 84 ؎ 1 mm Hg diastole. The diastolic BP of the M2 group was significantly lower than that of the C group (P Ͻ 0.0001). In patients aged у69 years, the diastolic BP of the M1 and M2 groups (M1: 77 ؎ 1 mm Hg; M2: 75 ؎ 1 mm Hg) were significantly lower than that of the C group (83 ؎ 1 mm Hg). The fasting blood glucose of the M1 and M2 groups was higher than that of the C group. The serum HDL cholesterol of the M1 group was lower than that of the other groups. These results suggest that, in addition to glucose and lipid metabolism disorders, low diastolic BP is associated with the onset of myocardial infarction, especially in reinfarction and in elderly hypertensive patients.
studies have assessed the relationship between BP levels and myocardial infarction risk by using multiple BP readings over 1 year before the onset of myocardial infarction.
We therefore analysed the average BP values for 1 year before the onset of myocardial infarction as well as metabolic variables in hypertensive patients with and without previous myocardial infarction who suffered from myocardial infarction and were admitted to the coronary care unit of our institute, in comparison with those of hypertensive patients who had no history of serious cardiovascular diseases.
Patients and methods
We performed the present study on 94 consecutive hypertensive patients who made monthly visits to the out-patient clinic of the National Cardiovascular Center for 1 year or more, and were admitted within 1 week after the onset of myocardial infarction at the coronary care unit of the same institute during the period from 1991 to 1995. Of these 94 patients, 42 had no history of prior myocardial infarction (M1 group; 27 men and 15 women, 69 ± 1 years, mean ± s.e.), while the other 52 had a history of prior myocardial infarction (M2 group; 43 men and nine women, 69 ± 1 years). In this study, one control hypertensive patient who had no history of serious cardiovascular diseases such as cerebrovascular disease, coronary heart disease and renal disease was selected for each myocardial infarction patient matched by age (± 2.5 years) and sex. All 94 of the myocardial infarction patients were pair-matched with control subjects. The control subjects (C group) were out-patients who made monthly visits to the out-patient clinic of our institute for 1 year or more.
Patients were diagnosed as having hypertension if they had evidence of systolic BP above 160 mm Hg or diastolic BP above 95 mm Hg, or if they had received anti-hypertensive medication. Infarction was defined as ischaemic pain lasting 20 Ͼ min with ST-T changes or pathological Q waves (ie, non-Qwave or Q-wave infarction) and a creatine kinase (CK) elevation more than twice the upper limit of normal, or an elevated CK-MB value.
Measurements
Each patient's BP was measured during each monthly visit in an office setting by the conventional cuff method with a sphygmomanometer. The patient remained seated for at least 5 min before the BP was measured. Diastolic BP was determined at the 5th Korotkoff sound. The averages of the BP values for 1 year before the onset of the myocardial infarction were used for the later analysis.
We also analysed several metabolic variables examined later during the 1-year period before the onset of myocardial infarction. Fasting blood glucose was determined with the glucose oxidase method using an Auto & Stat GA-1160 Analyzer (KDK Co, Kyoto, Japan). Serum creatinine, total cholesterol, high-density lipoprotein (HDL) cholesterol and triglycerides were measured enzymatically with a TBA-80M Analyzer (Toshiba Co, Tokyo, Japan).
We coded a 12-lead resting electrocardiogram of each patient recorded during the 1-year period before the onset of myocardial infarction according to the revised Minnesota code. 13 High QRS voltage (code 3.1 or 3.3) with and without ST-T changes (code 4.1-4.3 or 5.1-5.3) was considered to be electrocardiographic evidence of left ventricular hypertrophy.
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Statistical methods
All data are expressed as means ± s.e. Statistical analyses were performed using the chi-squared test or an analysis of variance (ANOVA) where appropriate. When a significant overall effect was detected by ANOVA, Scheffe's F test was used for the comparison of two variables. Multiple regression techniques were used to determine the association between BP, smoking habits, serum creatinine and metabolic variables. Analyses were performed using StatView-J 4.11 software (Abacus Concepts Inc, Berkeley, CA, USA), and a value of P Ͻ 0.05 was considered significant.
Results
The clinical characteristics of the study patients are shown in Table 1 . The mean age was 69 years in each group. The sex distribution, body mass index (BMI), smoking habits, duration of hypertension, use of anti-hypertensive medication and presence of left ventricular hypertrophy on electrocardiogram did not differ significantly among the three groups. In this study, only current smoking habits were assessed; thus, former smokers could not be distinguished from never-smokers. The serum creatinine levels were significantly higher in the M2 group compared with those in the C group (P Ͻ 0.001).
The majority of the patients in each group were taking anti-hypertensive drugs (M1: 90%; M2: 98%; C: 90%). The number of anti-hypertensive drugs used did not differ among the three groups (M1: 1.6 ± 0.2; M2: 1.6 ± 0.1; C: 1.5 ± 0.1). Of the various kinds of anti-hypertensive drugs, calcium antagonists were the most used in each group (M1: 86%; M2: 83%; C: 65%); the M1 and M2 patients were taking these drugs more than the C patients (P Ͻ 0.05). There were no differences in the use of other anti-hypertensive drugs such as ␤-adrenergic receptor blockers, angiotensin-converting enzyme inhibitors, diurtics and ␣ 1 -adrenergic receptors blockers among the three groups.
The average BPs for 1 year before the onset of myocardial infarction were 147 ± 2 mm Hg systole and 81 ± 2 mm Hg diastole in the M1 group, and 141 ± 2 mm Hg systole and 78 ± 1 mm Hg diastole in the M2 group, while those of the C group was 146 ± 1 mm Hg systole and 84 ± 1 mm Hg diastole ( Figure 1 ). The systolic BPs were similar among the three groups, whereas the diastolic BP of the M2 group was significantly lower than that of the C group (P Ͻ 0.0001).
Fasting blood glucose was 7.07 ± 0.40 mmol/l in the M1 group, 7.03 ± 0.52 mmol/l in the M2 group and 5.76 ± 0.13 mmol/l in the C group ( Table 2) . The blood glucose levels of the M1 and the M2 groups were significantly higher than those of the C group (Table 2 ; M1 vs C: P Ͻ 0.05; M2 vs C: P Ͻ 0.05). The serum total cholesterol and triglycerides were similar among the three groups. The serum HDL cholesterol level was 1.24 ± 0.05 mmol/l in the M1 group, 1.39 ± 0.05 mmol/l in the M2 group and 1.41 ± 0.08 mmol/l in the C group; that of the M1 group was significantly lower than that of the C group (P Ͻ 0.05).
With adjustments for smoking habits, serum creatinine, fasting blood glucose and serum HDL cholesterol, the averages of the systolic and diastolic BPs of the M1 group were found to be significantly associated with age (systolic: P Ͻ 0.05; diastolic: P Ͻ 0.05). Additional analyses were therefore performed for younger and older subjects using the median age of 69 years as a cut-off value. In the subjects aged Ͻ69 years, the sex distribution, BMI, smoking habits, duration of hypertension, use of anti-hypertensive medication and presence of left ventricular hypertrophy on electrocardiogram did not differ significantly among the three groups ( Table 3 ). The serum creatinine levels were signifi- 
Values are means ± s.e. M1: the first onset of myocardial infarction, M2: the recurrent onset of myocardial infarction, LVH: left ventricular hypertrophy, ECG: electrocardiogram. *P Ͻ 0.001 vs control patients.
Figure 1
The average BPs for the 1-year period before the onset of myocardial infarction in all subjects, in subjects aged Ͻ69 years, and in subjects aged у69 years. (`) indicates the hypertensive subjects of the first onset of myocardial infarction (M1 group; n = 42), (), the hypertensive subjects of the recurrent onset of myocardial infarction (M2 group; n = 52), and (), the control hypertensive subjects (C group; n = 94). In all subjects, the systolic BPs were similar among the three groups, whereas the diastolic BP of the M2 group was significantly lower than that of the C group. In the subjects aged Ͻ69 years, the systolic BP of the M1 group (n = 17) was significantly higher than those of the M2 group (n = 29) and the C group (n = 46), whereas the diastolic BP of the M2 group was significantly lower than those of the other two groups. In the subjects aged у69 years, the diastolic BPs of the M1 group (n = 25) and the M2 group (n = 23) were significantly lower than those of the C group (n = 48), whereas the systolic BPs were similar among the three groups. cantly higher in the M2 group compared with those in the C group (P Ͻ 0.01). In these subjects aged Ͻ69 years, the average BPs before the onset of myocardial infarction were 151 ± 4 mm Hg systole and 86 ± 3 mm Hg diastole in the M1 group, and 140 ± 2 mm Hg systole and 80 ± 1 mm Hg diastole in the M2 group, while those of the C group were 142 ± 2 mm Hg systole and 85 ± 1 mm Hg diastole; the systolic BP of the M1 group was significantly higher than those of the other two groups (M1 vs M2: P Ͻ 0.05; M1 vs C: P Ͻ 0.05), whereas the diastolic BP of the M2 group was significantly lower than those of the other two groups (M2 vs M1: P Ͻ 0.05; M2 vs C: P Ͻ 0.05). In the subjects aged у69 years, the sex distribution, BMI, smoking habits, duration of hypertension, and use of anti-hypertensive medication did not differ significantly among the three groups ( Table 4 ). The percentage of presence of left ventricular hypertrophy on electrocardiogram was significantly higher in the M1 and the M2 groups than in the C group (P Ͻ 0.05). The serum creatinine levels were significantly higher in the M2 group compared with those in the C group (P Ͻ 0.01). In these subjects aged у69 years, the average BPs before the onset of myocardial infarction were 143 ± 2 mm Hg systole and 77 ± 1 mm Hg diastole in the M1 group, and 142 ± 2 mm Hg systole and 75 ± 1 mm Hg diastole in the M2 group, and those of the C group were 150 ± 2 mm Hg systole and 83 ± 1 mm Hg diastole; the diastolic BPs of the M1 and the M2 groups were significantly lower than those of the C group (M1 vs C: P Ͻ 0.01; M2 vs C: P Ͻ 0.0001), whereas the systolic BPs were similar among the three groups.
Discussion
Clinical trials of treatments for elevated BP have shown that intervention with anti-hypertensive agents is associated with significant reductions in cardiovascular morbidity and mortality [16] [17] [18] . Despite these positive results, treated hypertensive patients still have a significantly greater risk of suffering cardiovascular complications than matched normotensive patients. One possible explanation for these results is that the reduction in BP was suboptimal.
In our patients aged Ͻ69 years, the average systolic BP before the first onset of myocardial infarction was higher compared with that of the control hypertensive patients who had no history of cardiovascular diseases. These results suggest that an insufficient lowering of elevated systolic BP could be, at least in part, one explanation of these patients' greater risk of coronary heart disease. However, in the present hypertensive patients with prior myocardial infarction, the level of systolic BP was not significantly different from that of the control patients, suggesting that this is not the case with patients who have pre-existing coronary heart disease. Another explanation is that an excessive lowering of BP may rather increase cardiovascular risks. Some studies have suggested that it may be dangerous to lower BP too far because the relationship between treated BP and risk appears to be J-shaped. For example, Cruickshank et al 10 showed that, in 900 hypertensive patients with pre-existing electrocardiogram abnormalities or symptoms of coronary heart disease, the risk of fatal myocardial infarction was greater when the treated diastolic BP was reduced to less than 85-90 mm Hg. Alderman et al 19 showed that patients whose diastolic BP had been reduced by less than 7 or greater than 17 mm Hg had a significantly greater risk of suffering a myocardial infarction than those whose diastolic BP had been reduced by 7-17 mm Hg. Moreover, recent studies suggested that a wide pulse pressure was associated with an increased incidence of subsequent cardiovascular complications. 20 Several investigators 11, 12 have suggested that reducing BP to the lower part of the normal range is harmful, especially in older patients. It has also been suggested that a J-curve or U-curve relation between diastolic BP and coronary heart disease death is observed independent of antihypertensive treatment. 21 In light of the present findings and those of a number of earlier studies, the J-shaped relationship between the level of diastolic BP and the risk of myocardial infarction should be kept in mind, especially when treating hypertensive patients with a history of myocardial infarction and elderly hypertensive patients, although the exact location of the lower point of the J-curve remains to be identified. Prospective and randomised trials are necessary to determine how far BP should be lowered to obtain the maximal reduction in coronary heart disease. This question is currently under investigation in several studies, such as the Hypertension Optimal Treatment (HOT) study. 22 It has been recently reported that the use of calcium antagonists, specifically nifedipine, may be associated with an increase in risk of myocardial infarction, 23, 24 although this issue remains controversial. In the present study, the hypertensive patients who suffered from myocardial infarction were taking calcium antagonists more than the hypertensive patients who had no history of serious cardiovascular diseases. Therefore, the use of calcium antagonists might have had some influence on the onset of myocardial infarction in these patients. Further prospective and randomised clinical trials are required to clarify the effects of calcium antagonists on cardiovascular morbidity and mortality in patients with hypertension.
In this study, the fasting blood glucose levels of the patients who experienced myocardial infarction were significantly higher than those of the control patients. Moreover, the serum HDL cholesterol level of the patients who suffered from the first myocardial infarction was significantly lower than that of the control group. These results are consistent with the findings of a number of epidemiological studies such as the Framingham study 25 and the Prospective Cardiovascular Munster (PROCAM) study. 26 These studies have shown that hypertension, diabetes mellitus and dyslipidaemia are independent risk factors for coronary heart disease. Therefore, preventive management of diabetes mellitus and dyslipidaemia must be taken into consideration in the treatment of hypertension.
In summary, the results of the present study suggest that, in addition to glucose and lipid metabolism disorders, low diastolic BP is associated with the onset of myocardial infarction, especially in reinfarction and in elderly hypertensive patients.
